Janus Henderson Group PLC Purchases New Shares in Contineum Therapeutics, Inc. (NASDAQ:CTNM)
Janus Henderson Group PLC purchased a new stake in Contineum Therapeutics, Inc. (NASDAQ:CTNM – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 68,320 shares of the company’s stock, valued at approximately $1,001,000. Janus Henderson Group PLC owned about 0.27% of Contineum Therapeutics […]
